Filing Flows › Balchem (BCPC) › R&D spending
Balchem (BCPC) R&D spending by quarter
Balchem's R&D spending was $5.3M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 7 quarters it ranged from $4.3M (Q2 2025) to $5.9M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.3M | +18% | +19% |
| Q2 2026 | $4.5M | -23% | +5% |
| Q1 2026 | $5.9M | +16% | +26% |
| Q4 2025 | $5.1M | +12% | — |
| Q3 2025 | $4.5M | +5% | — |
| Q2 2025 | $4.3M | -8% | — |
| Q1 2025 | $4.7M | — | — |
Q3 2026 at a glance
Balchem, Q3 2026: revenue $291M (+9% year over year), operating margin 21.5%, net earnings $46.7M, operating cash flow $69.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Balchem's R&D spending?
Balchem's R&D spending was $5.3M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has Balchem's R&D spending changed?
Over the last 7 quarters it ranged from $4.3M (Q2 2025) to $5.9M (Q1 2026).